Merdury Biopharmaceutical Corporation

A global leader in 3D powder printing pharmaceutical technology

A global leader in
3D powder printing pharmaceutical technology.

MerDury, inspired by Mercury, the messenger Hermes carries forward the mission of delivering innovations.

By transforming the “C” in Mercury into a “D,” which symbolizes our evolution into a driving force for 3D printing technologies in pharmaceuticals, redefining the future of medicine.

MerDury, inspired by Mercury, the messenger Hermes carries forward the mission of delivering innovations.

By transforming the “C” in Mercury into a “D,” which symbolizes our evolution into a driving force for 3D printing technologies in pharmaceuticals, redefining the future of medicine.

About Us

Merdury Biopharmaceutical Corporation (6932)
was established in 2019

With the vision of “Improving Human Health with Innovative Technology”, the company aims to satisfy the huge market and realize an easier and healthier future for the general public by adopting 3D printing as a new process to improve the bioavailability of drugs, flexibly control drug release, and provide a more convenient way of taking medicine.

Merdury’s exclusive StackDose™ new drug development technology platform provides 3D printing equipment dedicated to each drug, and works with partners to break through market demands that traditional drugs cannot meet.

With the vision of “Improving Human Health with Innovative Technology”, the company aims to satisfy the huge market and realize an easier and healthier future for the general public by adopting 3D printing as a new process to improve the bioavailability of drugs, flexibly control drug release, and provide a more convenient way of taking medicine.

Merdury’s exclusive StackDose™ new drug development technology platform provides 3D printing equipment dedicated to each drug, and works with partners to break through market demands that traditional drugs cannot meet.

StackDose™ Technology